Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (32)
Peng Xu, Yali Yi, Le Xiong, Yuxi Luo, Caifeng Xie, Daya Luo, Zhimin Zeng & Anwen Liu. (2024) Oncostatin M/Oncostatin M Receptor Signal Induces Radiation-Induced Heart Fibrosis by Regulating SMAD4 in Fibroblast. International Journal of Radiation Oncology*Biology*Physics 118:1, pages 203-217.
Crossref
Crossref
Raja Atreya. (2023) Prädiktion von Krankheitsverlauf und TherapieerfolgPrediction of disease progression and treatment success. Die Gastroenterologie.
Crossref
Crossref
Giorgio Guglielmi, Stefania Crucitta, Lorenzo Bertani, Martina Ruglioni, Giovanni Baiano Svizzero, Linda Ceccarelli, Marzia Del Re, Romano Danesi, Francesco Costa & Stefano Fogli. (2023) Expression of Circulating let-7e and miR-126 May Predict Clinical Remission in Patients With Crohn’s Disease Treated With Anti-TNF-α Biologics. Inflammatory Bowel Diseases.
Crossref
Crossref
Pablo A Olivera & Mark S Silverberg. (2023) Biomarkers That Predict Crohn’s Disease Outcomes. Journal of the Canadian Association of Gastroenterology.
Crossref
Crossref
Liang-Fang Wang, Ping-Run Chen, Si-Ke He, Shi-Hao Duan & Yan Zhang. (2023) Predictors and optimal management of tumor necrosis factor antagonist nonresponse in inflammatory bowel disease: A literature review. World Journal of Gastroenterology 29:29, pages 4481-4498.
Crossref
Crossref
M. V. Kruchinina, I. O. Svetlova, M. F. Osipenko, N. V. Abaltusova, A. A. Gromov, A. V. Borisova & E. V. Kruchinina. (2023) The significance of serum marker levels for assessing the status and prognosis of patients with inflammatory bowel disease. Experimental and Clinical Gastroenterology:4, pages 121-132.
Crossref
Crossref
Vanessa Mylenna Florêncio de Carvalho, Priscilla Stela Santana de Oliveira, Amanda Pinheiro Barros de Albuquerque, Moacyr Jesus Barreto de Melo Rêgo, Michelle Melgarejo da Rosa, Dinaldo Cavalcanti de Oliveira, Michelly Cristiny Pereira & Maira Galdino da Rocha Pitta. (2023) Diminuição dos Níveis Séricos do Receptor Solúvel da Oncostatina M (sOSMR) e Glicoproteína 130 (sgp130) em Pacientes com Doença Arterial Coronariana. Arquivos Brasileiros de Cardiologia 120:4.
Crossref
Crossref
Qingqing Du, Gao Tu, Yan Qian, Jingyi Yang, Xiaojun Yao & Weiwei Xue. (2023) Unbiased molecular dynamics simulation of a first-in-class small molecule inhibitor binds to oncostatin M. Computers in Biology and Medicine 155, pages 106709.
Crossref
Crossref
Bram Verstockt, Sare Verstockt, Jonathan Cremer, João Sabino, Marc Ferrante, Severine Vermeire & Padhmanand Sudhakar. (2023) Distinct transcriptional signatures in purified circulating immune cells drive heterogeneity in disease location in IBD. BMJ Open Gastroenterology 10:1, pages e001003.
Crossref
Crossref
Caiyu Guo, Fanye Zeng, Hui Liu, Jianlin Wang, Xue Huang & Judong Luo. (2022) Establish immune-related gene prognostic index for esophageal cancer. Frontiers in Genetics 13.
Crossref
Crossref
Guanglin Cui, Jon Florholmen & Rasmus Goll. (2022) Could Mucosal TNF Transcript as a Biomarker Candidate Help Optimize Anti-TNF Biological Therapy in Patients With Ulcerative Colitis?. Frontiers in Immunology 13.
Crossref
Crossref
Bram Verstockt, Miles Parkes & James C. Lee. (2022) How Do We Predict a Patient’s Disease Course and Whether They Will Respond to Specific Treatments?. Gastroenterology 162:5, pages 1383-1395.
Crossref
Crossref
Ying Cao, Yibei Dai, Lingyu Zhang, Danhua Wang, Qiao Yu, Wen Hu, Xuchu Wang, Pan Yu, Ying Ping, Tao Sun, Yiwen Sang, Zhenping Liu, Yan Chen & Zhihua Tao. (2022) Serum oncostatin M is a potential biomarker of disease activity and infliximab response in inflammatory bowel disease measured by chemiluminescence immunoassay. Clinical Biochemistry 100, pages 35-41.
Crossref
Crossref
Angela Guo, Cameron Ross, Nilesh Chande, Jamie Gregor, Terry Ponich, Reena Khanna, Michael Sey, Melanie Beaton, Brian Yan, Richard B. Kim & Aze Wilson. (2022) High oncostatin M predicts lack of clinical remission for patients with inflammatory bowel disease on tumor necrosis factor α antagonists. Scientific Reports 12:1.
Crossref
Crossref
Jing Shao, Yan Jin, Chunhong Shao, Hui Fan, Xiaorui Wang & Guang Yang. (2021) Serum exosomal pregnancy zone protein as a promising biomarker in inflammatory bowel disease. Cellular & Molecular Biology Letters 26:1.
Crossref
Crossref
Bradley J. Smith, Licia C. Silva-Costa & Daniel Martins-de-Souza. (2021) Human disease biomarker panels through systems biology. Biophysical Reviews 13:6, pages 1179-1190.
Crossref
Crossref
Jun Liu, Yadan Zhong, Huiting Liu, Huan Yang, Ping Lu, Yanqiang Shi, Xuan Wang, Wen Zheng, Xiaoling Yu, Yingping Xu & Bin Yang. (2021) Oncostatin M sensitizes keratinocytes to UVB-induced inflammation via GSDME-mediated pyroptosis. Journal of Dermatological Science 104:2, pages 95-103.
Crossref
Crossref
Xuhui Tong, Yuanyuan Zheng, Yu Li, Yongjian Xiong & Dapeng Chen. (2021) Soluble ligands as drug targets for treatment of inflammatory bowel disease. Pharmacology & Therapeutics 226, pages 107859.
Crossref
Crossref
Bram Verstockt, Nurulamin M Noor, Urko M Marigorta, Polychronis Pavlidis, Parakkal Deepak, Ryan C Ungaro, Claudio Fiocchi, Joana Torres & Michael Scharl. (2021) Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD—Disease Outcome and Response to Therapy. Journal of Crohn's and Colitis 15:9, pages 1431-1442.
Crossref
Crossref
Chuanhui Zhu, Qianqian Xia, Bin Gu, Mengjing Cui, Xing Zhang, Wenjing Yan, Dan Meng, Siyuan Shen, Shuqian Xie, Xueliang Li, Hua Jin & Shizhi Wang. (2021) Esophageal Cancer Associated Immune Genes as Biomarkers for Predicting Outcome in Upper Gastrointestinal Tumors. Frontiers in Genetics 12.
Crossref
Crossref
Qingqing Du, Yan Qian & Weiwei Xue. (2021) Cross-reactivity of two human IL-6 family cytokines OSM and LIF explored by protein-protein docking and molecular dynamics simulation. Biochimica et Biophysica Acta (BBA) - General Subjects 1865:7, pages 129907.
Crossref
Crossref
Guanglin Cui, Qingbo Fan, Zhenfeng Li, Rasmus Goll & Jon Florholmen. (2021) Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers. eBioMedicine 66, pages 103329.
Crossref
Crossref
Ki-Uk Kim, Jisu Kim, Wan-Hoon Kim, Hyeyoung Min & Chang Hwan Choi. (2021) Treatments of inflammatory bowel disease toward personalized medicine. Archives of Pharmacal Research 44:3, pages 293-309.
Crossref
Crossref
Kenji Kabashima & Hiroyuki Irie. (2021) Interleukin-31 as a Clinical Target for Pruritus Treatment. Frontiers in Medicine 8.
Crossref
Crossref
Yael Haberman, Phillip Minar, Rebekah Karns, Phillip J Dexheimer, Sudhir Ghandikota, Samuel Tegge, Daniel Shapiro, Brianne Shuler, Suresh Venkateswaran, Tzipi Braun, Allison Ta, Thomas D Walters, Robert N Baldassano, Joshua D Noe, Joel Rosh, James Markowitz, Jennifer L Dotson, David R Mack, Richard Kellermayer, Anne M Griffiths, Melvin B Heyman, Susan S Baker, Dedrick Moulton, Ashish S Patel, Ajay S Gulati, Steven J Steiner, Neal LeLeiko, Anthony Otley, Maria Oliva-Hemker, David Ziring, Ranjana Gokhale, Sandra Kim, Stephen L Guthery, Stanley A Cohen, Scott Snapper, Bruce J Aronow, Michael Stephens, Greg Gibson, Jonathan R Dillman, Marla Dubinsky, Jeffrey S Hyams, Subra Kugathasan, Anil G Jegga & Lee A Denson. (2021) Mucosal Inflammatory and Wound Healing Gene Programmes Reveal Targets for Stricturing Behaviour in Paediatric Crohn’s Disease. Journal of Crohn's and Colitis 15:2, pages 273-286.
Crossref
Crossref
Laurent Peyrin-Biroulet, William J. Sandborn, Remo Panaccione, Eugeni Domènech, Lieven Pouillon, Britta Siegmund, Silvio Danese & Subrata Ghosh. (2021) Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues. Therapeutic Advances in Gastroenterology 14, pages 175628482110599.
Crossref
Crossref
Hussein Mahajna & Shomron Ben-Horin. (2020) Novel bio-genetic predictors of response to biologic treatment in inflammatory bowel diseases. Current Opinion in Pharmacology 55, pages 132-140.
Crossref
Crossref
Mélanie M. Leroux, Zahra Doumandji, Laetitia Chézeau, Laurent Gaté, Sara Nahle, Romain Hocquel, Vadim Zhernovkov, Sylvie Migot, Jafar Ghanbaja, Céline Bonnet, Raphaël Schneider, Bertrand H. Rihn, Luc Ferrari & Olivier Joubert. (2020) Toxicity of TiO2 Nanoparticles: Validation of Alternative Models. International Journal of Molecular Sciences 21:14, pages 4855.
Crossref
Crossref
Anderson Rodrigues de Almeida, Andréa Tavares Dantas, Michelly Cristiny Pereira, Moacyr Jesus Barreto de Melo Rêgo, Rafaela Silva Guimarães Gonçalves, Ivan da Rocha Pitta, Angela Luzia Branco Pinto Duarte, Dulcineia Saes Parra Abdalla & Maira Galdino da Rocha Pitta. (2020) Increased levels of the soluble oncostatin M receptor (sOSMR) and glycoprotein 130 (sgp130) in systemic sclerosis patients and associations with clinical parameters. Immunobiology 225:3, pages 151964.
Crossref
Crossref
Peng Chen, Gaoshi Zhou, Jingxia Lin, Li Li, Zhirong Zeng, Minhu Chen & Shenghong Zhang. (2020) Serum Biomarkers for Inflammatory Bowel Disease. Frontiers in Medicine 7.
Crossref
Crossref
Qingqing Du, Yan Qian & Weiwei Xue. (2020) Molecular Simulation of Oncostatin M and Receptor (OSM–OSMR) Interaction as a Potential Therapeutic Target for Inflammatory Bowel Disease. Frontiers in Molecular Biosciences 7.
Crossref
Crossref
Nunzia Labarile, Subrata Ghosh, Siew C Ng, Julian Walters & Marietta Iacucci. (2020) Tests that now deserve to be more widely adopted in IBD clinical practice. Therapeutic Advances in Gastroenterology 13, pages 175628482094408.
Crossref
Crossref